| Literature DB >> 11468761 |
J P Higgins1, A Whitehead, R M Turner, R Z Omar, S G Thompson.
Abstract
Meta-analyses using individual patient data are becoming increasingly common and have several advantages over meta-analyses of summary statistics. We explore the use of multilevel or hierarchical models for the meta-analysis of continuous individual patient outcome data from clinical trials. A general framework is developed which encompasses traditional meta-analysis, as well as meta-regression and the inclusion of patient-level covariates for investigation of heterogeneity. Unexplained variation in treatment differences between trials is considered as random. We focus on models with fixed trial effects, although an extension to a random effect for trial is described. The methods are illustrated on an example in Alzheimer's disease in a classical framework using SAS PROC MIXED and MLwiN, and in a Bayesian framework using BUGS. Relative merits of the three software packages for such meta-analyses are discussed, as are the assessment of model assumptions and extensions to incorporate more than two treatments. Copyright 2001 John Wiley & Sons, Ltd.Entities:
Mesh:
Substances:
Year: 2001 PMID: 11468761 DOI: 10.1002/sim.918
Source DB: PubMed Journal: Stat Med ISSN: 0277-6715 Impact factor: 2.373